Literature DB >> 26153067

A subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades.

Ilhame Ameqrane, Ameqrane Ilhame1, Nicolas Wattiez, Wattiez Nicolas, Pierre Pouget, Pouget Pierre, Marcus Missal, Missal Marcus.   

Abstract

RATIONALE: It has been shown that antagonism of the glutamatergic N-methyl-D-aspartate (NMDA) receptor with subanesthetic doses of ketamine perturbs the perception of elapsed time. Anticipatory eye movements are based on an internal representation of elapsed time. Therefore, the occurrence of anticipatory saccades could be a particularly sensitive indicator of abnormal time perception due to NMDA receptors blockade.
OBJECTIVES: The objective of this study was to determine whether the occurrence of anticipatory saccades could be selectively altered by a subanesthetic dose of ketamine.
METHODS: Three Rhesus monkeys were trained in a simple visually guided saccadic task with a variable delay. Monkeys were rewarded for making a visually guided saccade at the end of the delay. Premature anticipatory saccades to the future position of the eccentric target initiated before the end of the delay were not rewarded. A subanesthetic dose of ketamine (0.25 mg/kg) or a saline solution of the same volume was injected i.m. during the task.
RESULTS: We found that the injected dose of ketamine did not induce sedation or abnormal behavior. However, in ∼4 min, ketamine induced a strong reduction of the occurrence of anticipatory saccades but did not reduce the occurrence of visually guided saccades.
CONCLUSION: This unexpected reduction of anticipatory saccade occurrence could be interpreted as resulting from an altered use of the perception of elapsed time during the delay period induced by NMDA receptors antagonism.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26153067     DOI: 10.1007/s00213-015-4005-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  52 in total

Review 1.  What makes us tick? Functional and neural mechanisms of interval timing.

Authors:  Catalin V Buhusi; Warren H Meck
Journal:  Nat Rev Neurosci       Date:  2005-10       Impact factor: 34.870

2.  Effects of pharmacologically induced changes in NMDA receptor activity on human timing and sensorimotor performance.

Authors:  Thomas H Rammsayer
Journal:  Brain Res       Date:  2006-01-19       Impact factor: 3.252

3.  Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task.

Authors:  Christine A Carroll; Brian F O'Donnell; Anantha Shekhar; William P Hetrick
Journal:  Brain Cogn       Date:  2009-08-06       Impact factor: 2.310

Review 4.  Cellular basis of working memory.

Authors:  P S Goldman-Rakic
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

5.  Ketamine perturbs perception of the flow of time in healthy volunteers.

Authors:  Jennifer T Coull; Hannah Morgan; Victoria C Cambridge; James W Moore; Francesco Giorlando; Ram Adapa; Philip R Corlett; Paul C Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2011-05-21       Impact factor: 4.530

6.  Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.

Authors:  Guy A Higgins; Theresa M Ballard; Michel Enderlin; Marie Haman; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

7.  Timing dysfunctions in schizophrenia span from millisecond to several-second durations.

Authors:  Christine A Carroll; Brian F O'Donnell; Anantha Shekhar; William P Hetrick
Journal:  Brain Cogn       Date:  2009-03-17       Impact factor: 2.310

8.  Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study.

Authors:  Celia J A Morgan; Ali Mofeez; Brigita Brandner; Lesley Bromley; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2004-01-15       Impact factor: 4.530

9.  Implicit and explicit timing in oculomotor control.

Authors:  Ilhame Ameqrane; Pierre Pouget; Nicolas Wattiez; Roger Carpenter; Marcus Missal
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

10.  The effects of ketamine and risperidone on eye movement control in healthy volunteers.

Authors:  A Schmechtig; J Lees; A Perkins; A Altavilla; K J Craig; G R Dawson; J F William Deakin; C T Dourish; L H Evans; I Koychev; K Weaver; R Smallman; J Walters; L S Wilkinson; R Morris; S C R Williams; U Ettinger
Journal:  Transl Psychiatry       Date:  2013-12-10       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.